From a translational point of view, we demonstrate that patients with CRC overexpress POLR1A and CMYC, and thus, we propose that G4-mediated downregulation of ribosomal and CMYC genes exerted by GA would constitute an attainable approach for CRC treatment. Here, POLR1A is linked to colorectal carcinoma.